BCTX (BriaCell Therapeutics) Kacepetan wutah bathi saben saham ing taun lumaku

BriaCell Therapeutics (BCTX) is a highly regarded developer of innovative oncology treatments within the scientific community, with growth driven by successful Phase 2 trials. The annual net income per share chart illustrates financial stability, while 0.00 reflects the most recent value of the metric. The company's future is based on the ability of Bria-IMT therapy to activate the immune system to overcome metastatic breast cancer.

BCTX - Wutah bathi ing taun lumaku BriaCell Therapeutics Corp. ing rentang 04.07.2022 - 15.11.2026

Rincian metrik keuangan lan pasar BriaCell Therapeutics Corp. (BCTX)

- rega lan prakiraan konsensus rega:

Kutipan saham BriaCell Therapeutics Corp|BCTX - Prakiraan konsensus analis

- indikator valuasi pasar bisnis:

Nilai pasar BriaCell Therapeutics|BCTX - Nilai Total Perusahaan

- data ekuitas miturut neraca:

Ekuitas saben Saham BriaCell|BCTX - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku briacell.com|BCTX - Aset Agregat Perusahaan

- rincian utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi BriaCell Therapeutics|BCTX - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal BriaCell|BCTX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku BriaCell|BCTX - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan BriaCell|Likuiditas darurat briacell.com

- statistik bathi lan rasio pasar:

BCTX - Bathi resik perusahaan|Bathi sing dikarepake BriaCell Therapeutics|BCTX - Rasio rega marang bathi|Rega marang bathi mangsa ngarep BriaCell|BCTX - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan BriaCell Therapeutics Corp.|BCTX - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan BriaCell|BCTX - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan briacell.com|BCTX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep BriaCell Therapeutics

- informasi babagan volume dodolan lan pendapatan:

BCTX - Pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan BriaCell Therapeutics Corp|BCTX - Multiplikator P/S|Multiplikator Forward P/S BriaCell Therapeutics|BCTX - Wutah dodolan YoY sajrone rolas wulan kepungkur

Pambiji fundamental:BriaCell Therapeutics

This metric measures the year-over-year dynamics of net income per share, reflecting capital management efficiency and operating profitability. The current value of 0.00 demonstrates the rate of income change relative to the previous year. By analyzing the YoY net income per share growth rate, an investor can see the impact of costs associated with the clinical scaling of cancer immunotherapy. For BriaCell Therapeutics (BCTX), such fluctuations determine the cost of drug development. This is a key marker for assessing the risks and growth potential of the asset.

Pesaing langsung

Wutah bathi resik saben saham ing taun iki Merus Corp|IMMP (Immutep Ltd) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku anixa.com ANIX|Wutah bathi saben saham ing taun lumaku Atossa (ATOS)|Context Therapeutics Inc. - Wutah bathi saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Mersana Therapeutics MRSN|ESSA Pharma Inc. (EPIX) - Kacepetan wutah bathi saben saham ing taun lumaku|QTI: Wutah bathi resik saben saham ing taun iki